By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ipsogen 

Bât A, 2 bd Luce

Marseille    13008  France
Phone: 33-0-4-91-29-30-90 Fax: 33-0-4-91-29-30-99


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
TrovaGene, Inc., Achieves Intellectual Property Milestone Under License Agreement with Ipsogen 8/29/2012 10:00:34 AM
QIAGEN N.V. (QGEN) Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics 7/11/2011 6:19:21 AM
QIAGEN Inc. (QGEN) Plans to Buy Cancer MDx Firm Ipsogen for $101 Million 6/15/2011 9:30:06 AM
The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 1/11/2010 8:44:30 AM
Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting 7/10/2009 8:39:12 AM
Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays 5/4/2009 7:08:56 AM
Ipsogen Announces the CE Marking of its "ProfileQuant(R) WT1" Kit 3/16/2009 7:43:56 AM
Ipsogen Reinforces its Leadership in Molecular Diagnosis and Monitoring of Leukemia 1/12/2009 10:45:04 AM
Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer 11/24/2008 8:33:39 AM
Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer 11/24/2008 6:39:59 AM
123
//-->